Literature DB >> 2665976

Antibodies against Ku protein in sera from patients with autoimmune diseases.

M Yaneva1, F C Arnett.   

Abstract

Immunoaffinity-purified Ku protein was used to screen sera from patients with systemic lupus erythematosus (SLE), scleroderma, myositis and Sjögren's syndrome for anti-Ku antibodies in a quantitative immunoblot assay. Sixteen percent of the 159 studied sera were reactive with the Ku protein; significantly increased frequencies of anti-Ku antibodies were found in SLE (19%) and scleroderma (14%) sera. Patients with myositis and Sjögren's syndrome showed similar frequencies. All positive sera had antibodies to the 86 kD subunit of Ku protein; only one serum did not react with 70 kD subunit. Frequencies of other autoantibodies were compared in anti-Ku positive and negative patients. Only anti-Sm antibodies, especially in the absence of anti-nRNP, appear to be associated with the presence of anti-Ku antibodies. A strong correlation between anti-Ku antibodies and the class II HLA antigen DQw1 (89% of the positive sera) was observed, suggesting participation of MHC genes in the mounting of the anti-Ku immune response.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2665976      PMCID: PMC1541894     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  Linked sets of antinuclear antibodies: what do they mean?

Authors:  J E Craft; J A Hardin
Journal:  J Rheumatol Suppl       Date:  1987-06

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Increased frequencies of Sm and nRNP autoantibodies in American blacks compared to whites with systemic lupus erythematosus.

Authors:  F C Arnett; R G Hamilton; M G Roebber; J B Harley; M Reichlin
Journal:  J Rheumatol       Date:  1988-12       Impact factor: 4.666

5.  Precipitating antibody to D.N.A. detected by two-stage electroimmunodiffusion. Study in S.L.E. and in rheumatoid arthritis.

Authors:  G D Johnson; J P Edmonds; E J Holborow
Journal:  Lancet       Date:  1973-10-20       Impact factor: 79.321

Review 6.  The genetics of rheumatic disease in man.

Authors:  R Goldstein; F C Arnett
Journal:  Rheum Dis Clin North Am       Date:  1987-12       Impact factor: 2.670

7.  Enzyme immunoassay ELISA and EMIT.

Authors:  E Engvall
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

8.  Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap.

Authors:  T Mimori; M Akizuki; H Yamagata; S Inada; S Yoshida; M Homma
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808

9.  Autoantibody to centromere (kinetochore) in scleroderma sera.

Authors:  Y Moroi; C Peebles; M J Fritzler; J Steigerwald; E M Tan
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

10.  HLA-DR characterization of a Chippewa Indian subpopulation with high prevalence of rheumatoid arthritis.

Authors:  W B Bias; S H Hsu; M K Pollard; J Harvey; M T Lotze; F C Arnett; M B Stevens
Journal:  Hum Immunol       Date:  1981-03       Impact factor: 2.850

View more
  16 in total

1.  The La antigen associates with the human telomerase ribonucleoprotein and influences telomere length in vivo.

Authors:  L P Ford; J W Shay; W E Wright
Journal:  RNA       Date:  2001-08       Impact factor: 4.942

Review 2.  B-cell epitopes of autoantigenic DNA-binding proteins.

Authors:  C H Chou; M Satoh; J Wang; W H Reeves
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

3.  Cell surface expression of the 70-kD component of Ku, a DNA-binding nuclear autoantigen.

Authors:  B S Prabhakar; G P Allaway; J Srinivasappa; A L Notkins
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

Review 4.  Mixed connective tissue disease, overlap syndromes, and eosinophilic fasciitis.

Authors:  P J Maddison
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

Review 5.  Interaction of Ku protein and DNA-dependent protein kinase catalytic subunit with nucleic acids.

Authors:  W S Dynan; S Yoo
Journal:  Nucleic Acids Res       Date:  1998-04-01       Impact factor: 16.971

6.  Multistudy fine mapping of chromosome 2q identifies XRCC5 as a chronic obstructive pulmonary disease susceptibility gene.

Authors:  Craig P Hersh; Sreekumar G Pillai; Guohua Zhu; David A Lomas; Per Bakke; Amund Gulsvik; Dawn L DeMeo; Barbara J Klanderman; Ross Lazarus; Augusto A Litonjua; David Sparrow; John J Reilly; Alvar Agusti; Peter M A Calverley; Claudio F Donner; Robert D Levy; Barry J Make; Peter D Paré; Stephen I Rennard; Jørgen Vestbo; Emiel F M Wouters; Mary Beth Scholand; Hilary Coon; John Hoidal; Edwin K Silverman
Journal:  Am J Respir Crit Care Med       Date:  2010-05-12       Impact factor: 21.405

7.  The 86-kD subunit of Ku autoantigen mediates homotypic and heterotypic adhesion of multiple myeloma cells.

Authors:  G Teoh; M Urashima; E A Greenfield; K A Nguyen; J F Lee; D Chauhan; A Ogata; S P Treon; K C Anderson
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

Review 8.  Laboratory evaluation of the inflammatory myopathies.

Authors:  L G Rider; F W Miller
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

9.  Production and characterization of recombinant human Ku antigen.

Authors:  M Ono; P W Tucker; J D Capra
Journal:  Nucleic Acids Res       Date:  1994-09-25       Impact factor: 16.971

10.  Autoantibodies to DNA-dependent protein kinase. Probes for the catalytic subunit.

Authors:  A Suwa; M Hirakata; Y Takeda; Y Okano; T Mimori; S Inada; F Watanabe; H Teraoka; W S Dynan; J A Hardin
Journal:  J Clin Invest       Date:  1996-03-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.